Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Therapeutic effect of nintedanib on acute exacerbation of interstitial lung diseases.

Ito Y, Tazaki G, Kondo Y, Takahashi G, Sakamaki F.

Respir Med Case Rep. 2019 Feb 28;26:317-320. doi: 10.1016/j.rmcr.2019.02.021. eCollection 2019.

2.

An Autopsy Case of Paradoxical Pulmonary Thromboembolism by Arteriovenous Fistula from Right Common Iliac Artery to Common Iliac Vein: A Rare Cause of Pulmonary Embolism.

Takahashi F, Hiraiwa S, Takahashi G, Kondo Y, Tasaki G, Sugiyama T, Tajiri T, Sakamaki F.

Am J Case Rep. 2018 Nov 1;19:1301-1305. doi: 10.12659/AJCR.910982.

3.

Prognostic Understanding at Diagnosis and Associated Factors in Patients with Advanced Lung Cancer and Their Caregivers.

Sato T, Soejima K, Fujisawa D, Takeuchi M, Arai D, Nakachi I, Naoki K, Kawada I, Yasuda H, Ishioka K, Nukaga S, Kobayashi K, Masaki K, Inoue T, Hikima K, Nakamura M, Ohgino K, Oyamada Y, Funatsu Y, Terashima T, Miyao N, Sayama K, Saito F, Sakamaki F, Betsuyaku T.

Oncologist. 2018 Oct;23(10):1218-1229. doi: 10.1634/theoncologist.2017-0329. Epub 2018 Aug 17.

4.

A Stepwise Embolization Strategy for a Bronchial Arterial Aneurysm: Proximal Coil and Distal Glue with the Optional Use of a Microballoon Occlusion System.

Mine T, Matsumoto T, Hayashi T, Tomita K, Masuda K, Kawashima M, Sakamaki F, Hasebe T.

Cardiovasc Intervent Radiol. 2018 Aug;41(8):1267-1273. doi: 10.1007/s00270-018-1969-1. Epub 2018 Apr 23.

PMID:
29687263
5.

Real-world Efficacy and Safety of Nivolumab for Advanced Non-Small-cell Lung Cancer: A Retrospective Multicenter Analysis.

Kobayashi K, Nakachi I, Naoki K, Satomi R, Nakamura M, Inoue T, Tateno H, Sakamaki F, Sayama K, Terashima T, Koh H, Abe T, Nishino M, Arai D, Yasuda H, Kawada I, Soejima K, Betsuyaku T; Keio Lung Oncology Group (KLOG).

Clin Lung Cancer. 2018 May;19(3):e349-e358. doi: 10.1016/j.cllc.2018.01.001. Epub 2018 Jan 5.

PMID:
29398578
6.

Autopsy Findings in A Case of Pulmonary Langerhans Cell Histiocytosis-Associated Pulmonary Hypertension.

Taniyama D, Kamata H, Miyamoto K, Mashimo S, Sakamaki F.

Am J Case Rep. 2017 Dec 30 [revised 2018 Jan 1];18:1401-1406. doi: 10.12659/AJCR.905860. No abstract available.

7.

Characteristics of severe asthma with fungal sensitization.

Masaki K, Fukunaga K, Matsusaka M, Kabata H, Tanosaki T, Mochimaru T, Kamatani T, Ohtsuka K, Baba R, Ueda S, Suzuki Y, Sakamaki F, Oyamada Y, Inoue T, Oguma T, Sayama K, Koh H, Nakamura M, Umeda A, Kamei K, Izuhara K, Asano K, Betsuyaku T.

Ann Allergy Asthma Immunol. 2017 Sep;119(3):253-257. doi: 10.1016/j.anai.2017.07.008. Epub 2017 Aug 8.

PMID:
28801088
8.

Erlotinib as second- or third-line treatment in elderly patients with advanced non-small cell lung cancer: Keio Lung Oncology Group Study 001 (KLOG001).

Miyawaki M, Naoki K, Yoda S, Nakayama S, Satomi R, Sato T, Ikemura S, Ohgino K, Ishioka K, Arai D, Namkoong H, Otsuka K, Miyazaki M, Tani T, Kuroda A, Nishino M, Yasuda H, Kawada I, Koh H, Nakamura M, Terashima T, Sakamaki F, Sayama K, Betsuyaku T, Soejima K.

Mol Clin Oncol. 2017 Mar;6(3):409-414. doi: 10.3892/mco.2017.1154. Epub 2017 Feb 6.

9.

Pulmonary Hypertension and Inflammation/Infection.

Sakamaki F.

Intern Med. 2016;55(11):1409-10. doi: 10.2169/internalmedicine.55.6415. Epub 2016 Jun 1. No abstract available.

10.

Prognostic significance of persistent restrictive filling pattern after cardiac resynchronization therapy.

Yamamoto M, Seo Y, Ishizu T, Kawamatsu N, Sato K, Sugano A, Atsumi A, Harimura Y, Machino-Ohtsuka T, Sakamaki F, Aonuma K.

J Echocardiogr. 2015 Mar;13(1):20-6. doi: 10.1007/s12574-014-0234-0. Epub 2014 Dec 3.

PMID:
26184518
11.

Left bundle branch block and echocardiography in the era of CRT.

Seo Y, Ishizu T, Sakamaki F, Yamamoto M, Aonuma K.

J Echocardiogr. 2015 Mar;13(1):6-14. doi: 10.1007/s12574-014-0233-1. Epub 2014 Nov 26. Review.

PMID:
26184516
12.

Phenotype of asthma related with high serum periostin levels.

Matsusaka M, Kabata H, Fukunaga K, Suzuki Y, Masaki K, Mochimaru T, Sakamaki F, Oyamada Y, Inoue T, Oguma T, Sayama K, Koh H, Nakamura M, Umeda A, Ono J, Ohta S, Izuhara K, Asano K, Betsuyaku T.

Allergol Int. 2015 Apr;64(2):175-80. doi: 10.1016/j.alit.2014.07.003. Epub 2014 Oct 22.

13.

Multi-institutional retrospective cohort study of patients with severe pulmonary hypertension associated with respiratory diseases.

Tanabe N, Taniguchi H, Tsujino I, Sakamaki F, Emoto N, Kimura H, Takamura K, Hanaoka M, Nishimura M, Tatsumi K; JRS Lung Disease PH Study Group.

Respirology. 2015 Jul;20(5):805-12. doi: 10.1111/resp.12530. Epub 2015 Mar 31.

14.

Variability in amplitude and stimulation threshold values in motor evoked potential (MEP) monitoring during the resection of brain lesions.

Okamoto E, Ishikawa E, Yamamoto T, Matsuda M, Nakai K, Matsushita A, Masuda Y, Akutsu H, Ayuzawa S, Sakamaki F, Matsumoto Y, Matsumura A.

Clin Neurophysiol. 2015 Jun;126(6):1271-1278. doi: 10.1016/j.clinph.2014.10.005. Epub 2014 Oct 12.

PMID:
25454280
15.

Analysis of continuous first-line treatment with docetaxel and carboplatin for advanced non-small cell lung cancer.

Aoki T, Ebihara A, Yogo Y, Suemasu K, Sakamaki F.

Oncol Lett. 2014 Jun;7(6):1771-1777. Epub 2014 Mar 14.

16.

Current trends in the management of pulmonary hypertension associated with respiratory disease in institutions approved by the Japanese Respiratory Society.

Tanabe N, Taniguchi H, Tsujino I, Sakamaki F, Emoto N, Kimura H, Miyaji K, Takamura K, Hayashi S, Hanaoka M, Tatsumi K; Japanese Respiratory Society Lung Disease Pulmonary Hypertension Study Group.

Respir Investig. 2014 May;52(3):167-72. doi: 10.1016/j.resinv.2013.11.003. Epub 2013 Dec 18.

PMID:
24853016
17.

[An outbreak of Streptococcus pneumoniae serotype 11A pneumonia at a nursing home, Tokyo, 2009].

Kikuchi T, Sakamaki F, Taniyama D, Tsuchihashi Y, Yamagishi T, Kitahara M.

Kansenshogaku Zasshi. 2014 Mar;88(2):149-54. Japanese.

PMID:
24783456
18.

Novel dyssynchrony evaluation by M-mode imaging in left bundle branch block and the application to predict responses for cardiac resynchronization therapy.

Sakamaki F, Seo Y, Atsumi A, Yamamoto M, Machino-Ohtsuka T, Kawamura R, Yamasaki H, Igarashi M, Sekiguchi Y, Ishizu T, Aonuma K.

J Cardiol. 2014 Sep;64(3):199-206. doi: 10.1016/j.jjcc.2013.12.013. Epub 2014 Feb 24.

19.

Analysis of comorbid factors that increase the COPD assessment test scores.

Miyazaki M, Nakamura H, Chubachi S, Sasaki M, Haraguchi M, Yoshida S, Tsuduki K, Shirahata T, Takahashi S, Minematsu N, Koh H, Nakamura M, Sakamaki F, Terashima T, Sayama K, Jones PW, Asano K, Betsuyaku T; Keio COPD Comorbidity Research (K-CCR) Group.

Respir Res. 2014 Feb 6;15:13. doi: 10.1186/1465-9921-15-13.

20.

Nonbacterial thrombotic endocarditis leading to acute heart failure due to aortic stenosis in a patient with lung cancer.

Taniyama D, Yamamoto R, Kawasaki M, Kamata H, Miyamoto K, Mashimo S, Sakamaki F.

Intern Med. 2013;52(14):1617-20. Epub 2013 Jul 15.

21.

A pneumopericardium caused by gastric ulcer perforation.

Taniyama D, Miyamoto K, Mashimo S, Sakamaki F.

Intern Med. 2013;52(11):1277. No abstract available.

22.

Time-course of ventilation, arterial and pulmonary CO(2) tension during CO (2) increase in humans.

Satoh T, Okada Y, Hara Y, Sakamaki F, Kyotani S, Tomita T, Nagaya N, Nakanishi N.

Adv Exp Med Biol. 2012;758:63-70. doi: 10.1007/978-94-007-4584-1_9.

PMID:
23080144
23.

Tissue Doppler imaging dyssynchrony parameter derived from the myocardial active wall motion improves prediction of responders for cardiac resynchronization therapy.

Sakamaki F, Seo Y, Ishizu T, Yanaka S, Atsumi A, Yamamoto M, Machino-Ohtsuka T, Kawamura R, Yamasaki H, Igarashi M, Yoshida K, Sekiguchi Y, Tada H, Aonuma K.

Circ J. 2012;76(3):689-97. Epub 2012 Jan 13.

24.

[Strategy for marginally resectable lung cancer].

Kaji M, Kobayashi R, Hino Y, Masai K, Miyahara N, Sakamaki F, Miyamoto K, Kamata H, Taniyama D, Suemasu K.

Gan To Kagaku Ryoho. 2011 Aug;38(8):1256-60. Japanese.

PMID:
21829062
25.

End-systolic and end-diastolic left atrial volume assessment by two-dimensional echocardiography: a comparison study with magnetic resonance imaging.

Uno K, Seo Y, Ishizu T, Inaba T, Sakamaki F, Iida N, Nakajima H, Oyake Y, Ohtsuka S, Tanaka Y, Minami M, Watanabe S, Aonuma K.

J Echocardiogr. 2010 Jun;8(2):52-8. doi: 10.1007/s12574-010-0035-z. Epub 2010 Feb 11.

PMID:
27278661
26.

Mechanical dyssynchrony assessed by speckle tracking imaging as a reliable predictor of acute and chronic response to cardiac resynchronization therapy.

Seo Y, Ishizu T, Sakamaki F, Yamamoto M, Machino T, Yamasaki H, Kawamura R, Yoshida K, Sekiguchi Y, Kawano S, Tada H, Watanabe S, Aonuma K.

J Am Soc Echocardiogr. 2009 Jul;22(7):839-46. doi: 10.1016/j.echo.2009.04.029.

PMID:
19560661
27.

[A case of adult T-cell leukemia/lymphoma with primary lung cancer].

Miyahara H, Itou H, Sekine A, Taniyama D, Katsui T, Tanaka W, Satou R, Kurihara A, Satou Y, Sakamaki F.

Nihon Kokyuki Gakkai Zasshi. 2009 Apr;47(4):342-6. Japanese.

PMID:
19455967
28.

Analysis of the origin of cardiac wall motion that constitutes myocardial velocity-time curves in patients with left bundle branch block.

Seo Y, Ishizu T, Sakamaki F, Yamamoto M, Machino T, Watanabe S, Aonuma K.

J Am Soc Echocardiogr. 2009 Apr;22(4):331-6. doi: 10.1016/j.echo.2009.01.019.

PMID:
19345303
29.

[Unexplained pulmonary arterial hypertension in a patient with lung resection, treated with sildenafil and beraprost].

Shimokawa M, Sakamaki F, Aoki T, Yogo Y, Ebihara A.

Nihon Kokyuki Gakkai Zasshi. 2006 Nov;44(11):817-22. Japanese.

PMID:
17144579
30.

Sleep disordered breathing in patients with chronic obstructive pulmonary disease.

Aoki T, Akinori E, Yogo Y, Sakamaki F, Suzuki Y, Suemasu K.

COPD. 2005 Jun;2(2):243-52.

PMID:
17136951
31.

Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension.

Itoh T, Nagaya N, Ishibashi-Ueda H, Kyotani S, Oya H, Sakamaki F, Kimura H, Nakanishi N.

Respirology. 2006 Mar;11(2):158-63.

PMID:
16548900
32.

Assessment of quality of life with 5 different scales in patients participating in comprehensive cardiac rehabilitation after acute myocardial infarction.

Suzuki S, Takaki H, Yasumura Y, Sakuragi S, Takagi S, Tsutsumi Y, Aihara N, Sakamaki F, Goto Y.

Circ J. 2005 Dec;69(12):1527-34.

33.

Mixed venous CO2 and ventilation during exercise and CO2-rebreathing in humans.

Satoh T, Okada Y, Hara Y, Sakamaki F, Kyotani S, Tomita T.

Adv Exp Med Biol. 2004;551:269-74. No abstract available.

PMID:
15602974
34.

Increase in thrombomodulin concentrations after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension.

Sakamaki F, Kyotani S, Nagaya N, Sato N, Oya H, Nakanishi N.

Chest. 2003 Oct;124(4):1305-11.

PMID:
14555559
35.

Attenuation by intravenous 2-chloroadenosine of acute lung injury induced by live escherichia coli or latex particles added to endotoxin in the neutropenic state.

Sakamaki F, Ishizaka A, Urano T, Sayama K, Nakamura H, Terashima T, Waki Y, Soejima K, Tasaka S, Sawafuji M, Kobayashi K, Yamaguchi K, Kanazawa M.

J Lab Clin Med. 2003 Aug;142(2):128-35.

PMID:
12960960
36.

Patients with large myocardial infarction gain a greater improvement in exercise capacity after exercise training than those with small to medium infarction.

Sakuragi S, Takagi S, Suzuki S, Sakamaki F, Takaki H, Aihara N, Yasumura Y, Goto Y.

Clin Cardiol. 2003 Jun;26(6):280-6.

37.

Attenuation of hypercapnic carbon dioxide chemosensitivity after postinfarction exercise training: possible contribution to the improvement in exercise hyperventilation.

Tomita T, Takaki H, Hara Y, Sakamaki F, Satoh T, Takagi S, Yasumura Y, Aihara N, Goto Y, Sunagawa K.

Heart. 2003 Apr;89(4):404-10.

38.

Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension.

Nagaya N, Sasaki N, Ando M, Ogino H, Sakamaki F, Kyotani S, Nakanishi N.

Chest. 2003 Feb;123(2):338-43.

PMID:
12576349
39.

Effects of continuous IV prostacyclin in a patient with pulmonary veno-occlusive disease.

Okumura H, Nagaya N, Kyotani S, Sakamaki F, Nakanishi N, Fukuhara S, Yutani C.

Chest. 2002 Sep;122(3):1096-8.

PMID:
12226062
40.

Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterectomy.

Nagaya N, Ando M, Oya H, Ohkita Y, Kyotani S, Sakamaki F, Nakanishi N.

Ann Thorac Surg. 2002 Jul;74(1):180-4; discussion 184.

PMID:
12118754
41.

Higher prevalence of obstructive airway disease in patients with thoracic or abdominal aortic aneurysm.

Sakamaki F, Oya H, Nagaya N, Kyotani S, Satoh T, Nakanishi N.

J Vasc Surg. 2002 Jul;36(1):35-40.

42.

Serum uric acid level increases in proportion to the severity of pulmonary thromboembolism.

Shimizu Y, Nagaya N, Satoh T, Uematsu M, Kyotani S, Sakamaki F, Nakanishi N, Miyatake K.

Circ J. 2002 Jun;66(6):571-5.

43.

Poor prognosis and related factors in adults with Eisenmenger syndrome.

Oya H, Nagaya N, Uematsu M, Satoh T, Sakamaki F, Kyotani S, Sato N, Nakanishi N, Miyatake K.

Am Heart J. 2002 Apr;143(4):739-44.

PMID:
11923814
44.

Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension.

Nagaya N, Shimizu Y, Satoh T, Oya H, Uematsu M, Kyotani S, Sakamaki F, Sato N, Nakanishi N, Miyatake K.

Heart. 2002 Apr;87(4):340-5.

45.

Acute and chronic effects of surgical thromboendarterectomy on exercise capacity and ventilatory efficiency in patients with chronic thromboembolic pulmonary hypertension.

Iwase T, Nagaya N, Ando M, Satoh T, Sakamaki F, Kyotani S, Takaki H, Goto Y, Ohkita Y, Uematsu M, Nakanishi N, Miyatake K.

Heart. 2001 Aug;86(2):188-92.

46.

Pulmonary artery reflection for differentially diagnosing primary pulmonary hypertension and chronic pulmonary thromboembolism.

Nakayama Y, Nakanishi N, Hayashi T, Nagaya N, Sakamaki F, Satoh N, Ohya H, Kyotani S.

J Am Coll Cardiol. 2001 Jul;38(1):214-8.

47.
48.

Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension.

Nagaya N, Uematsu M, Oya H, Sato N, Sakamaki F, Kyotani S, Ueno K, Nakanishi N, Yamagishi M, Miyatake K.

Am J Respir Crit Care Med. 2001 Mar;163(4):887-91.

PMID:
11282761
49.

[Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension].

Nagaya N, Nishikimi T, Uematsu M, Satoh T, Kyotani S, Sakamaki F, Kakishita M, Fukushima K, Okano Y, Nakanishi N, Miyatake K, Kangawa K.

J Cardiol. 2001 Feb;37(2):110-1. Japanese.

PMID:
11255693
50.

[Pulmonary thromboendarterectomy for chronic pulmonary thromboembolism in three patients with systemic lupus erythematosus and antiphospholipid syndrome].

Sato N, Kyotani S, Sakamaki F, Nagaya N, Oya H, Nakanishi N.

Nihon Kokyuki Gakkai Zasshi. 2000 Dec;38(12):958-64. Japanese.

PMID:
11244736

Supplemental Content

Loading ...
Support Center